MARKET

HALO

HALO

Halozyme Thrp
NASDAQ
67.12
-2.09
-3.02%
After Hours: 67.00 -0.13 -0.19% 17:34 05/15 EDT
OPEN
69.21
PREV CLOSE
69.21
HIGH
69.66
LOW
66.31
VOLUME
2.14M
TURNOVER
--
52 WEEK HIGH
82.22
52 WEEK LOW
47.50
MARKET CAP
7.96B
P/E (TTM)
24.14
1D
5D
1M
3M
1Y
5Y
1D
A Look At Halozyme Therapeutics (HALO) Valuation After Q1 Growth, GSK ENHANZE Deal And US$1b Buyback
Simply Wall St · 1d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Halozyme (HALO) and Vor Biopharma (VOR)
TipRanks · 1d ago
Halozyme Therapeutics (HALO) Q1 EPS Rebound Tests Bearish Margin Compression Narrative
Simply Wall St · 2d ago
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know
Barchart · 2d ago
Company News for May 13, 2026
NASDAQ · 2d ago
Halozyme Earnings Call Highlights Royalty-Fueled Growth
TipRanks · 3d ago
Halozyme Therapeutics Price Target Cut to $93.00/Share From $96.00 by Morgan Stanley
Dow Jones · 3d ago
Halozyme Therapeutics Is Maintained at Overweight by Morgan Stanley
Dow Jones · 3d ago
More
About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing solutions to improve patient experiences and outcomes for emerging and established therapies. The Company's commercially-validated solution, ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, is used to facilitate the subcutaneous delivery of injected drugs and fluids, with a focus on improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine ENHANZE with its partners’ proprietary compounds. It also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED. It also has a proprietary ultra-high concentration microparticle formulation technology for biologics, branded Hypercon.

Webull offers Halozyme Therapeutics, Inc. stock information, including NASDAQ: HALO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HALO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HALO stock methods without spending real money on the virtual paper trading platform.